90 filings
Page 4 of 5
UPLOAD
y5renhrw 0jofg
4 Jan 21
Letter from SEC
12:00am
8-K
ukpwxu3c
30 Dec 20
Codiak Reports Positive Initial Phase 1 Results for exoIL-12™ Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers
8:00am
DRS
v6l7ofbjoo583c31me2j
29 Dec 20
Draft registration statement
12:00am
8-K
qrwxysf4wvoll
20 Nov 20
Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress
4:32pm
10-Q
2sckz97t
19 Nov 20
Quarterly report
4:30pm
S-8
i52lcjmd
16 Oct 20
Registration of securities for employees
12:00am
424B4
qcnsz2d7bz5vlvuqzm
14 Oct 20
Prospectus supplement with pricing info
4:56pm
EFFECT
6wook7
14 Oct 20
Notice of effectiveness
12:15am
CERT
jfw6dkka8 5d
13 Oct 20
Certification of approval for exchange listing
1:13pm
8-A12B
tjqmcrnogfrq
13 Oct 20
Registration of securities on exchange
6:13am
CORRESP
4au2r3dzsaisk1
8 Oct 20
Correspondence with SEC
12:00am
CORRESP
fsjxylau
8 Oct 20
Correspondence with SEC
12:00am
CORRESP
nxdj81shi8g4
5 Oct 20
Correspondence with SEC
12:00am
UPLOAD
w6duboj
2 Oct 20
Letter from SEC
12:00am
CORRESP
6y4 gf94jy
25 Sep 20
Correspondence with SEC
12:00am
CORRESP
pkhx mvsj
23 Sep 20
Correspondence with SEC
12:00am
UPLOAD
zi0j0we7
18 Sep 20
Letter from SEC
12:00am
CORRESP
dfr5u7ct6prnzqd
9 Sep 20
Correspondence with SEC
12:00am